Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell-derived cardiomyocytes with a MYBPC3 mutation.
Hangyuan QiuYaxun SunZiwei PanJingjun ZhouHongkun WangXiaochen WangDongsheng CaiGuosheng FuTingyu GongChenyang JiangPing LiangPublished in: Clinical and translational medicine (2022)